Registration is Paramount: Delhi High Court Upholds Injunction in Mayo Clinic Trademark Case - 2026-05-23

Protecting the Mark: Delhi High Court Clamps Down on Unauthorized Use of 'MAYO'

In a significant ruling for intellectual property rights, the Delhi High Court has affirmed an interim injunction restraining a group of Indian charitable trusts and hospitals from using the trademark “MAYO.” The decision underscores a fundamental principle of the Trade Marks Act, 1999: the statutory rights granted by valid trademark registration remain robust, even when the registrant has not yet commenced extensive commercial activity in the country.

A Dispute Across Borders

The respondent, the renowned US-based Mayo Foundation for Medical Education and Research , sought to prevent the Bodhisattva Charitable Trust and its affiliates from operating under names like “Mayo Medical Centre” and “Mayo Hospital.” The respondent argued that its registration of “MAYO” and “MAYO CLINIC” dated back to 1992 in India, granting it exclusive rights. Conversely, the appellants contended that their institutions had been providing healthcare services in India for years, arguing that the respondent’s delay in taking action constituted acquiescence and that the term “Mayo” had entered common usage.

The Arguments: Priority, User, and Intent

The appellants challenged the injunction on several grounds: * Acquiescence: They argued that the respondent was aware of their operations since 2011/2012 yet waited years to initiate legal action, effectively waiving their right to object. * Common Usage: The appellants claimed “MAYO” is a common Indian name (referencing the former Viceroy of India), arguing that no singular entity should be able to monopolize it. * Priority of User: They maintained that since their use of the mark in India predated the respondent’s relevant Class 41 (Education) registration, they held priority.

The Mayo Foundation countered by pointing to their 1992 registrations, asserting that the appellants' adoption of the name was not a coincidence but a strategic effort to capitalize on the global reputation of the Mayo Clinic . They highlighted that the appellants themselves had acknowledged the influence of the US-based institution in their own marketing materials, rendering their adoption of the name dishonest.

Legal Analysis: The Primacy of Registration

The Division Bench, led by Justice C. Hari Shankar, dismantled the appellants' arguments by focusing on the mechanics of the Trade Marks Act. The Court clarified that commercial use is not a sine qua non for an infringement action. Under Section 28(1), the mere fact of a valid registration confers an exclusive right to the user, and this status is prima facie evidence of validity under Section 31.

The Court held that the appellants could not use Section 34 of the Act to protect their usage because their adoption occurred after the respondent’s earlier registrations. Furthermore, the Court rejected the “acquiescence” claim, citing the respondent’s earlier cease-and-desist notices, which effectively neutralized the claim that the organization had sat idle while their rights were being infringed.

Key Observations

The judgment delivered by Justice C. Hari Shankar offers a precise roadmap for future trademark litigation:

• "Commercial user of the mark is not required in order for an infringement action to lie. The right to relief against infringement is provided, under Section 28(1), consequent on the factum of registration of a mark."
• "The respondent having put the appellant on notice regarding the infringing use, by it, of the MAYO mark... it cannot be said that the respondent had acquiesced to the use of the mark by the appellants."
• "Section 31(1) of the Trade Marks Act unequivocally provides that the very registration of a trade mark shall be prima facie evidence of its validity in all legal proceedings."
• "In cases of infringement either of trade mark or of copyright, normally an injunction must follow. Mere delay in bringing action is not sufficient to defeat grant of injunction in such cases."

Final Verdict: Implications for Medical Brands

The Delhi High Court’s refusal to interfere with the single Judge's order signals a strict approach regarding trademark protection in India. By dismissing the appeal, the Court has reinforced that trademark registration is a powerful, standalone asset. For healthcare providers and educational institutions, the ruling serves as a vital reminder: adopting a globally recognized name under the guise of “common usage” remains a high-risk endeavor that will unlikely withstand judicial scrutiny when the registry holds the historical record. Future entities must prioritize thorough due diligence and original branding to avoid the costly legal consequences of infringement.